Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00365599
Status:
COMPLETED
Last Update Posted:
2014-11-21
First Post:
2006-08-15
Brief Title:
Phase II Trial of SAHA Tamoxifen for Patients With Breast Cancer
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Selective estrogen receptor modulatorsSERMS | View |
| Breast cancer | View |
| Suberoylanilide hydroxamic acid SAHA | View |
| Vorinostat | View |
| Tamoxifen | View |
| Anti-hormonal therapy | View |
| Estrogen receptor positive | View |
| Progesterone receptor positive | View |
| Metastatic disease | View |
| Aromatase inhibitors Ais | View |
| Histone deacetylase HDAC inhibitors | View |